ZL
Zai Lab
ZLAB·NASDAQShanghai CNFounded 20141,200 employees
Mid CapbiotechPublicOncologyNeurology
Platform: CN Licensing
Market Cap
$2.5B
All Drugs
3
Clinical Trials
6
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ZLAB)
Loading ZLAB stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talavorutinib | ZLA-4375 | NDA/BLA | 2 | Cl18.2 | FL | ||
| Bemabrutinib | ZLA-4277 | Phase 1 | 2 | GPRC5D | NBCF | ||
| Voxarapivir | ZLA-2463 | Phase 2 | 2 | GPRC5D | Hemophilia ALGS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)